Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00318591 · ClinicalTrials.gov registry record · NA
Comparative Study of Intermittent Catheters and Occurrence of Urinary Tract Infections
A NA study of Urinary Tract Infections, sponsored by Coloplast A/S.
- Completed
- Registry status
- NA
- Development phase
- 219
- Enrollment target
- 16
- Study locations
NCT00318591: Completed NA study of Urinary Tract Infections, sponsored by Coloplast A/S.
NCT00318591 is a NA study of Urinary Tract Infections that has completed, run by Coloplast A/S. The registered enrollment target is 219 participants, below the 452-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (52% lower). The trial reports 16 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00318591, a NA study of Urinary Tract Infections, has completed, sponsored by Coloplast A/S.
- COMPLETED
- Registry status
- NA
- Development phase
- 219 participants
- Enrollment target
- 16
- Study locations
Study Summary
The purpose of this study is to investigate the frequency of urinary tract infections with symptoms in spinal cord injured patients requiring intermittent catheterization for emptying the bladder. Patients will use either a coated catheter or an uncoated catheter with gel.
Primary Outcome
Occurrence of symptomatic urinary tract infections (UTIs). Time to first UTI
Conditions Studied
Interventions
- DEVICE SpeediCath
- DEVICE Conveen Uncoated
Study Locations (16)
California
- Rancho Los Amigos National Rehabilitation Center - Downey
- Santa Clara Valley Medical Center - San Jose
Ontario
- Parkwood Rehabilitation Centre - London
- Toronto Rehabilitation Centre - Toronto
Colorado
- Craig Hospital - Englewood
Florida
- University of Miami - Miami
Georgia
- Shepherd Center - Atlanta
Massachusetts
- Boston Medical School - Boston
Michigan
- University of Michigan Helaths Systems - Ann Arbor
Minnesota
- Mayo Clinic, Saint Mary Hospital MB3CF Rehabilitation - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2006-04 |
| Est. Completion | 2009-10 |
| Phase | NA |
What the finished NCT00318591 record still lists
NCT00318591 is an interventional study that assigns participants to a tested intervention. The registered 219 participants enrollment target is mid-sized for trials with a published cap, below the 452-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Urinary Tract Infections appearing as the primary indexed condition, and to 2 interventions - of which SpeediCath is the first listed.
NCT00318591 lists 16 locations in 14 states (California, Ontario, Colorado).
Frequently Asked Questions
What is clinical trial NCT00318591 about?
NCT00318591 is a clinical study titled "Comparative Study of Intermittent Catheters and Occurrence of Urinary Tract Infections". The purpose of this study is to investigate the frequency of urinary tract infections with symptoms in spinal cord injured patients requiring intermittent catheterization for emptying the bladder. Patients will use either a coated catheter or an uncoated catheter with gel.
What is the current status of trial NCT00318591?
This trial is currently completed. It is a NA study. The enrollment target is 219 participants. The study started on 2006-04. Estimated completion is 2009-10.
What conditions does trial NCT00318591 study?
This clinical trial studies the following conditions: Urinary Tract Infections.
What interventions are being tested in trial NCT00318591?
The interventions under investigation include: SpeediCath (DEVICE), Conveen Uncoated (DEVICE).
Who is sponsoring clinical trial NCT00318591?
This trial is sponsored by Coloplast A/S, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00318591 being conducted?
This trial has 16 study locations across California, Colorado, Florida, Georgia, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00318591's enrollment target sits among peer trials
219 15th of 34 higher than 20 of 34 other Urinary Tract Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Tract Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
RECRUITING · NA
-
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
RECRUITING · NA
-
Double Voiding and Post-transplant UTI
RECRUITING · NA
-
Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture
RECRUITING · NA
-
Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Peezy for DAB
ACTIVE NOT RECRUITING · NA
-
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05196035 · 219 participants · Phase 3
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
- NCT05608434 · 219 participants · Phase 1
Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
- NCT05773144 · 219 participants · NA
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
- NCT05907980 · 219 participants · Phase 1
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia